Unfortunately, the Ecopipam study has been discontinued. Dr. Gerald Maguire is focusing on the Noema Pharma (NOE-105) trial. This is also in phase 2, but only in the US and Australia. Neuralink, in my opinion, will never get approval for something like this. I think it's because of ethical reasons or because of unpredictable complications. If Neuralink gets an FDA trial, it will still take more than 10-15 years. Otherwise there is currently no "hope" at all